Association between polymorphisms in period genes and bone density in postmenopausal Korean women

References

• NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–95
   PubMed Web of Science ®Google Scholar
• Leali PT, Muresu F, Melis A, Ruggiu A, Zachos A, Doria C. Skeletal fragility definition. Clin Cases Miner Bone Metab 2011;8:11–13
   PubMedGoogle Scholar
• Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003;14(Suppl 3):S13–18
   PubMedGoogle Scholar
• Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385–97
   PubMed Web of Science ®Google Scholar
• Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J. Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum 1995;38:61–7
   PubMed Web of Science ®Google Scholar
• Yang X. A wheel of time: the circadian clock, nuclear receptors, and physiology. Genes Dev 2010;24:741–7
   PubMed Web of Science ®Google Scholar
• Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell 2005;122:803–15
   PubMed Web of Science ®Google Scholar
• Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004;5:407–41
   PubMed Web of Science ®Google Scholar
• Perreau-Lenz S, Pevet P, Buijs RM, Kalsbeek A. The biological clock: the bodyguard of temporal homeostasis. Chronobiol Int 2004;21:1–25
   PubMed Web of Science ®Google Scholar
• Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem 2010;285:25103–8
   PubMed Web of Science ®Google Scholar
• Chubb SA. Measurement of C-terminal telopeptide of type I collagen (CTX) in serum. Clin Biochem 2012;45:928–35
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 1997;60:419–23
   PubMed Web of Science ®Google Scholar
• Joseph F, Chan BY, Durham BH, et al. The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion. J Clin Endocrinol Metab 2007;92:3230–8
   PubMed Web of Science ®Google Scholar
• Hanyu R, Hayata T, Nagao M, et al. Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH. J Cell Biochem 2011;112:433–8
   PubMed Web of Science ®Google Scholar
• Albrecht U, Zheng B, Larkin D, Sun ZS, Lee CC. MPer1 and mper2 are essential for normal resetting of the circadian clock. J Biol Rhythms 2001;16:100–4
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137–41
   PubMed Web of Science ®Google Scholar
• Chu LW, Zhu Y, Yu K, et al. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev 2008; 17:3268–73
   PubMed Web of Science ®Google Scholar
• Lazar AS, Slak A, Lo JC, et al. Sleep, diurnal preference, health, and psychological well-being: a prospective single-allelic- variation study. Chronobiol Int 2012;29:131–46
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim L, Kang SG, et al. PER2 variation is associated with diurnal preference in a Korean young population. Behav Genet 2011;41:273–7
   PubMed Web of Science ®Google Scholar
• Ojeda DA, Perea CS, Nino CL, et al. A novel association of two non-synonymous polymorphisms in PER2 and PER3 genes with specific diurnal preference subscales. Neurosci Lett 2013; 553:52–6
   PubMed Web of Science ®Google Scholar
• Viola AU, Chellappa SL, Archer SN, et al. Interindividual differences in circadian rhythmicity and sleep homeostasis in older people: effect of a PER3 polymorphism. Neurobiol Aging 2012;33:1010 e17–27
   PubMedGoogle Scholar
• Zhao B, Lu J, Yin J, et al. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma. Liver Int 2012;32:1451–9
   PubMed Web of Science ®Google Scholar
• Zheng B, Albrecht U, Kaasik K, et al. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001;105:683–94
   PubMed Web of Science ®Google Scholar
• Mangiacavalli S, Pochintesta L, Cocito F, et al. Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma. Br J Haematol 2013; 162:555–8
   PubMed Web of Science ®Google Scholar
• Saramaki O, Visakorpi T. Chromosomal aberrations in prostate cancer. Front Biosci 2007;12:3287–301
   PubMed Web of Science ®Google Scholar
• Stephens DM, Byrd JC. Chronic lymphocytic leukemia with del(17p13.1): a distinct clinical subtype requiring novel treatment approaches. Oncology (Williston Park) 2012;26:1044–54
   PubMed Web of Science ®Google Scholar
• Liu H, Li B. p53 control of bone remodeling. J Cell Biochem 2010;111:529–34
   PubMed Web of Science ®Google Scholar
• Rapuri PB, Gallagher JC, Haynatzki G. Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women. J Clin Endocrinol Metab 2004;89:4954–62
   PubMed Web of Science ®Google Scholar
• Tuck SP, Scane AC, Fraser WD, Diver MJ, Eastell R, Francis RM. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures. Bone 2008;43:999–1005
   PubMed Web of Science ®Google Scholar
• Xiao Y, Cui J, Li YX, Shi YH, Le GW. Expression of genes associated with bone resorption is increased and bone formation is decreased in mice fed a high-fat diet. Lipids 2010;45:345–55
   PubMed Web of Science ®Google Scholar
• van Geel TA, Geusens PP, Winkens B, Sels JP, Dinant GJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol 2009;160:681–7
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Beck TJ, et al. Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. J Clin Endocrinol Metab 2009;94:853–60
   PubMed Web of Science ®Google Scholar
• Specker BL, Binkley T, Vukovich M, Beare T. Volumetric bone mineral density and bone size in sleep-deprived individuals. Osteoporos Int 2007;18:93–9
   PubMed Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. Melatonin and the skeleton. Osteoporos Int 2013;24:2919–27
   PubMed Web of Science ®Google Scholar
• Maganhin CC, Carbonel AA, Hatty JH, et al. [Melatonin effects on the female genital system: a brief review]. Rev Assoc Med Bras 2008;54:267–71
   PubMed Web of Science ®Google Scholar
• Maria S, Witt-Enderby PA. Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures. J Pineal Res 2013 Dec 26. doi: 10.1111/jpi.12116. Epub ahead of print
   Web of Science ®Google Scholar
• Wang WM, Yuan P, Wang JY, et al. [Association of genetic variantions of circadian clock genes and risk of breast cancer]. Zhonghua Zhong Liu Za Zhi 2013;35:236–9
   PubMedGoogle Scholar
• von Schantz M. Phenotypic effects of genetic variability in human clock genes on circadian and sleep parameters. J Genet 2008; 87:513–19
   PubMed Web of Science ®Google Scholar